ARTV Competitors & Alternatives
Compare Artiva Biotherapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
ARTV
Main Stock$8.93
Tradestie Score
51
Market Cap
$71.32M
Revenue Growth
-1.0%
Analyst Upside
+300.9%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$41.30
|
$505.12M | 2.2 | 62 | Compare |
|
RGNX
REGENXBIO Inc.
|
$12.75
|
$493.52M | - | 62 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$92.17
|
$492.21M | - | 56 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 56 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$10.21
|
$468.01M | - | 54 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$21.98
|
$463.20M | - | 59 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$9.72
|
$457.09M | - | 60 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$6.36
|
$454.29M | - | 58 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$20.41
|
$448.32M | - | 60 | Compare |
More ARTV Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry